Worldwide Pneumonia Vaccines Market Outlook to 2025: High Costs Associated With the Development of Such Vaccines Restrain Market Growth

World News: . []

Dublin, July 12, 2019 (GLOBE NEWSWIRE) -- The report has been added to offering. The Global Pneumonia Vaccines Market size is expected to reach $9.6 billion by 2025, rising at a market growth of 5.1% CAGR during the forecast period.The key factors that drive the growth of the global pneumonia vaccine market include an increase in the prevalence of pneumonia across the globe, rise in government focus on immunization programs for pneumonia, and introduction of novel pneumococcal vaccines such as PCV10.However, longer timelines required for pneumonia vaccine production and high costs associated with the development of such vaccines restrain the market growth. 1.1 Market Definition1.2 Objectives1.3 Market Scope1.4 Segmentation1.4.1 Global Pneumonia Vaccines Market, by Vaccine Type1.4.2 Global Pneumonia Vaccines Market, by Product Type1.4.3 Global Pneumonia Vaccines Market, by Sector1.4.4 Global Pneumonia Vaccines Market, by Distribution Channel1.4.5 Global Pneumonia Vaccines Market, by Region1.5 Methodology for the Research2.1 Introduction2.1.1 Overview2.2 Key Factors Impacting the Market2.2.1 Market Drivers2.2.2 Market Restraints3.1 Global Pneumococcal Conjugate Vaccine (PCV) Market by Region3.2 Global Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region4.1 Global Prevnar 13 Market by Region4.2 Global Synflorix Market by Region4.3 Global Pneumovax 23 Market by Region5.1 Global Private sector Market by Region5.2 Global Public sector Market by Region6.1 Global Distribution Partner Companies Market by Region6.2 Global Non-Governmental Organizations (NGO) Market by Region6.3 Global Government Authorities Market by Region7.1 North America Pneumonia Vaccines Market7.2 Europe Pneumonia Vaccines Market7.3 Asia-Pacific Pneumonia Vaccines Market7.4 LAMEA Pneumonia Vaccines Market8.1 GlaxoSmithKline PLC (GSK)8.2 LG Corporation (LG Chemicals Ltd.)8.3 Panacea Biotec Limited8.4 Pfizer Inc.8.5 PnuVax Incorporated8.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)8.7 Shenzhen Kangtai Biological Products Co. Ltd. (Beijing Minhai Biotechnology Corporation Limited)8.8 SK Holdings Co. Ltd. (SK Bioscience Inc.)8.9 Walvax Biotechnology Co. Ltd.8.10 Merck & Co. Inc. For more information about this report visit

Research and Markets also offers services providing focused, comprehensive and tailored research.


CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines, Pulmonary Medicine

More news and information about Research and Markets

Published By:

Globe Newswire: 12:14 GMT Friday 12th July 2019

Published: .

Search for other references to "worldwide" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us